Signalling by the Wnt family of secreted lipoproteins has essential functions in development and disease 1 . The canonical Wnt/bcatenin pathway requires a single-span transmembrane receptor, low-density lipoprotein (LDL)-receptor-related protein 6 (LRP6) [2] [3] [4] , whose phosphorylation at multiple PPPSP motifs is induced upon stimulation by Wnt and is critical for signal transduction 5 . The kinase responsible for LRP6 phosphorylation has not been identified. Here we provide biochemical and genetic evidence for a 'dual-kinase' mechanism for LRP6 phosphorylation and activation. Glycogen synthase kinase 3 (GSK3), which is known for its inhibitory role in Wnt signalling through the promotion of b-catenin phosphorylation and degradation, mediates the phosphorylation and activation of LRP6. We show that Wnt induces sequential phosphorylation of LRP6 by GSK3 and casein kinase 1, and this dual phosphorylation promotes the engagement of LRP6 with the scaffolding protein Axin. We show further that a membrane-associated form of GSK3, in contrast with cytosolic GSK3, stimulates Wnt signalling and Xenopus axis duplication. Our results identify two key kinases mediating Wnt co-receptor activation, reveal an unexpected and intricate logic of Wnt/b-catenin signalling, and illustrate GSK3 as a genuine switch that dictates both on and off states of a pivotal regulatory pathway.
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Canonical Wnt signalling operates through regulating the phosphorylation and degradation of the transcription co-activator b-catenin 1, 6 . Without stimulation by Wnt, b-catenin is assembled into the Axin complex, in which b-catenin is sequentially phosphorylated by casein kinase 1 (CK1) and GSK3 and earmarked for degradation [7] [8] [9] . Stimulation by Wnt leads to the inhibition of b-catenin phosphorylation and degradation. This signal transduction is initiated at the plasma membrane by two distinct receptors, a Frizzled serpentine receptor and LRP6 or LRP5, which together may form a Wnt-induced Frizzled-LRP6 (or LRP5) complex 3, 6, [10] [11] [12] . Although the mechanism by which this receptor pair initiates signalling remains to be understood, Wnt-induced LRP6 phosphorylation at a PPPSP motif, which is reiterated five times in the cytoplasmic domain of LRP5/6 (Fig. 1a) , has a crucial function 5 . (For simplicity we use PPPSP to represent PPPSP or PPPTP). Indeed, LRP6 mutants lacking these motifs or harbouring substitutions at the S/T residues are inactive in signalling 5, 13 . Conversely, a single PPPSP motif, on transfer to a heterologous receptor, is sufficient to initiate b-catenin signalling 5 . Because the phosphorylated PPPSP motif mediates LRP5/6-Axin interaction 5, 14 , we proposed a model 5 in which Wnt-induced LRP6 phosphorylation promotes the recruitment of Axin by LRP6, thereby permitting the Wnt receptor complex to regulate b-catenin phosphorylation directly 14 . MEFs. b-Actin was used as a loading control. e, GSK3b(R96A) phosphorylated LRP6 PPPSP motif, but not b-catenin S33/S37/T41, detected with a phosphorylation-specific antibody 7 . GSK3bKM phosphorylated neither LRP6 nor b-catenin.
We tested whether the PPPSP kinase might associate with LRP6 and/or Axin, because Axin overexpression enhanced LRP6 PPPSP phosphorylation 5 . Glutathione S-transferase (GST)-LRP6C, a fusion protein between GST and the LRP6 cytoplasmic domain, and Axin each precipitated from 293T cell extracts an associated PPPSP kinase ( Supplementary Figs 1 and 2) . We suspected the involvement of GSK3. First, we isolated GSK3a in a yeast two-hybrid screen, using LRP6C as bait, and confirmed this interaction in yeast (not shown), indicating that GSK3 might bind LRP6. Second, GSK3 associates with Axin. Third, GSK3 is a proline-directed kinase that prefers (S/T)P for phosphorylation and was predicted by Scansite 2.0 (ref. 15 ) to phosphorylate the PPPSP motif. Finally, GSK3 overexpression promotes LRP5-Axin interaction 14 , which is consistent with the possibility that GSK3 might do so through the phosphorylation of LRP5/6. Indeed, the PPPSP kinase associated with GST-LRP6C or Axin was inhibited in vitro by LiCl or SB216763, two GSK3 inhibitors 16, 17 ( Supplementary Figs 1 and 2 ). In vivo, GSK3 overexpression promoted LRP6 PPPSP phosphorylation (Fig. 1b) , whereas LiCl and SB216763 prevented Wnt-induced LRP6 PPPSP phosphorylation (Fig. 1c) . Wnt-induced LRP6 phosphorylation was abolished in mouse embryo fibroblasts (MEFs) harbouring genetic deletions of the Gsk3a and Gsk3b genes (Fig. 1d) . These data show that GSK3 is involved in LRP6 PPPSP phosphorylation.
Phosphorylation of many substrates by GSK3 requires a priming kinase 17 ; for b-catenin this is CK1 (refs 7-9) . None of the S/Tresidues in LRP6 PPPSP motifs and flanking regions (Fig. 1a) conforms to the priming phosphorylation consensus 7, 17 , indicating a possibly priming-independent GSK3 phosphorylation. We tested this possibility with GSK3b(R96A), which has alanine substituted for arginine 96 and is incapable of recognizing priming phosphorylation [18] [19] [20] [21] . GSK3b(R96A) was inactive in b-catenin phosphorylation 21 but active in LRP6 PPPSP phosphorylation (Fig. 1e ). GSK3 therefore phosphorylates LRP6 and b-catenin by means of distinct mechanisms.
A single PPPSP motif on transfer to a truncated LDL receptor (LDLRDN) is sufficient to activate the Wnt pathway 5 . During characterization of this motif, we noticed a second S/T (site II) Supplementary Fig. 4 ). Left, LDLRDN-PPPSP/derivatives. Ab1490 and Ab1493 specifically recognized the phosphorylated, more slowly migrating, band. Right, GSK3b promoted LRP6 phosphorylation at site I and site II. g, h, LRP6 phosphorylation at site I and site II was induced by Wnt3a CM in MEFs (g) but not in MEFs lacking Gsk3a and Gsk3b (h). Luciferase activity is presented as fold induction compared with the control (mean^s.d.).
three amino-acid residues downstream of the PPPSP phosphorylation site (site I, Fig. 2a ). Site II is present in all PPPSP motifs (Fig. 1a) and is conserved in Drosophila Arrow 4 , the orthologue of LRP5/6; it was included in the flanking residues in the LDLRDN-PPPSP construct 5 ( Fig. 2a) . Replacing the site II threonine with alanine in LDLRDN-PPPSP, like replacing the site I serine with alanine, diminished its signalling activity in a T-cell factor (TCF)/b-catenin reporter assay (Fig. 2b) . We demonstrated the importance of site II S/T residues in the full-length LRP6. LRP6m5 0 , which harbours an alanine substitution of all five S/T residues at site II, was much less active than LRP6, alone or in synergy with Wnt3a, in the TCF/bcatenin reporter assay (Fig. 2c, d ). LRP6m5 and LRP6m10, which have an alanine substitution of five site-I S/Tresidues 5 and of five site-I plus five site-II S/T residues, respectively, were inactive alone or in synergy with Wnt3a (Fig. 2c, d ). When expressed more highly they each behaved as a dominant-negative mutant and suppressed Wnt3a signalling (Fig. 2e) . Therefore site I is essential for, and site II augments, Wnt/LRP6 signalling.
Site II, like site I, was phosphorylated (Fig. 2f, g ), as detected by means of a phospho-specific antibody (Ab1493, for phosphorylated T1493 in LRP6; Supplementary Fig. 3 ). LDLRDN-PPPSP, which is constitutively active, showed constitutive phosphorylation at site I and site II (Fig. 2f) . Wnt3a induced rapid LRP6 phosphorylation at site I and site II (Fig. 2g) . Phosphorylation of the extended PPPSPxS motif therefore correlates fully with Wnt/LRP6 signalling.
In both LDLRDN-PPPSP and LRP6, mutation at site I abolished phosphorylation at both site I and site II, whereas mutation at site II had no effect on site I phosphorylation (Fig. 2f) . The simplest explanation is that the phosphorylation of site I by GSK3 both primes and is required for site II phosphorylation. Indeed, GSK3 overexpression increased LRP6 phosphorylation at site I and site II (Fig. 2f) , whereas a lack of GSK3 prevented Wnt-induced LRP6 phosphorylation at either site I or site II (Fig. 2h) .
We considered that the site II kinase is not GSK3 because the order and spacing between site II and site I phosphorylation are not what GSK3 requires. In fact site II resembles the CK1 phosphorylation consensus (S/T)*xx(S/T), in which (S/T)* is a priming phosphorylated residue and xx is any two-amino acid combination 22 . 25 . Because of the multiplicity of the CK1 family, we used the specific dominant-negative (DN) CK1 mutants DN-CK1a and DN-CK1d. DN-CK1a inhibits CK1a but not CK1d/1, whereas DN-CK1d inhibits CK1d/1 but not CK1a (S.L. and X.H., unpublished observations). DN-CK1a plus DN-CK1d, but neither alone, prevented Wnt-induced phosphorylation at site II but not at site I (Fig. 3a) . Thus CK1 probably phosphorylates site II after phosphorylation of the priming site I by GSK3, and CK1a (and CK1a2) and CK1d/1 may have redundant roles in the process.
We showed that Axin preferentially binds to a phosphorylated PPPSP motif in LDLRDN-PPPSP and LRP6 (ref. 5), which are also phosphorylated at site II (Fig. 2f, g ). The site II mutation diminished Axin binding to the PPPSPxS motif, whereas the site I mutation abolished it (Fig. 3b) . Phosphorylation at both site I and site II is therefore required for Axin recognition in vivo. We reconstituted GST-LRP6C phosphorylation in vitro by means of recombinant GSK3 and/or CK1 (Fig. 3c ). GSK3 and CK1 phosphorylated site I and site II, respectively, and GSK3 phosphorylation of site I enhanced CK1 phosphorylation of site II (Fig. 3c) . GST-LRP6C phosphorylated by GSK3 plus CK1, but not by GSK3 or CK1 alone, exhibited strong Axin-binding capability (Fig. 3c) . This binding of Axin required the intact PPPSPxS motifs, because GST-LRP6Cm5 (site I mutated in all five motifs), GST-LRP6Cm5 0 (site II mutated in all five motifs) and GST-LRP6Cm10 (site I plus site II mutated in all five motifs) were defective in Axin interaction (Fig. 3d) . Phosphorylation of the PPPSPxS motif by GSK3 and CK1 is therefore essential for the recruitment of Axin by LRP6.
The phosphorylation of LRP6 by CK1 offers a mechanism to account, in part, for a documented activating role of CK1 in Wnt/bcatenin signalling. However, our results that GSK3 is required for LRP6 phosphorylation and activation depart drastically from the dogma that GSK3 is solely an inhibitor of Wnt signalling by means of its role in b-catenin phosphorylation and degradation. We proposed that different pools of GSK3 have distinct functions in the Wnt pathway. In this model, cytosolic GSK3 phosphorylates b-catenin together with CK1 and thus antagonizes Wnt/b-catenin signalling, whereas plasma-membrane-associated GSK3 phosphorylates LRP6 together with CK1 in response to Wnt stimulation and activates Wnt/b-catenin signalling. We found significant amounts of membrane-associated GSK3 and CK1, which did not change appreciably with or without Wnt stimulation (Fig. 4a) . We then generated mGSK3, a GSK3 mutant that targets GSK3 to the plasma membrane by means of a mini-transmembrane unit, LDLRDN 5 . mGSK3, like GSK3, stimulated LRP6 phosphorylation (Fig. 4b) . However, in sharp contrast to GSK3, which antagonized LRP6 signalling, mGSK3 synergized with LRP6 in activating the TCF/bcatenin reporter (Fig. 4c) . mGSK3 did not synergize with LRP6m5 (Fig. 4d) and therefore depended on the PPPSP motif for its stimulatory activity. In Xenopus embryos, mGSK3 plus LRP6 induced axis duplication and the expression of Xnr3 (Fig. 4e, f) , a TCF/b-catenin target. GSK3 in the proximity of the plasma membrane therefore mediates Wnt/LRP6 signalling by phosphorylating the PPPSP motif.
We have provided biochemical, genetic and functional evidence that GSK3 and CK1 sequentially phosphorylate PPPSPxS motifs in LRP6 on stimulation by Wnt, and this dual-kinase phosphorylation underlies LRP6 activation by promoting Axin recruitment through phosphorylated LRP6. The critical function of GSK3 in mediating Wnt/b-catenin signalling is probably performed by membraneassociated GSK3, which acts to antagonize b-catenin phosphorylation and degradation by cytosolic GSK3. These opposing functions of GSK3 in a single pathway are unprecedented but may be separated spatially and temporally. How Wnt induces LRP6 phosphorylation by GSK3 and CK1 remains unknown. Because GSK3 and CK1 exhibit membrane association regardless of Wnt stimulation, Wnt may control the access of GSK3 to LRP6. Alternatively, Wnt may inhibit a phosphatase that counteracts the constitutive LRP6 phosphorylation by GSK3 and CK1. Our study further implies that in Drosophila, Arrow is probably activated by GSK3/Zeste-White 3/Shaggy or another GSK3-related protein (see refs 11, 26, 27) .
Sequential phosphorylation of LRP6 and b-catenin mirror each other; that is, they are regulated by Wnt in opposite directions and use GSK3 and CK1 as the mutual priming kinase. However, in both cases GSK3 phosphorylation seems to be the main regulatory step, whereas CK1 phosphorylation may be constitutive. GSK3 uses distinct mechanisms to phosphorylate b-catenin (a primed substrate) and LRP6 (a non-primed substrate). Our findings also uncover further striking parallels between the Wnt and Hedgehog (Hh) pathways. In the absence of Hh, protein kinase A and CK1 (and GSK3) sequentially phosphorylate transcription factor Ci for processing Ci into a repressor, thus suppressing Hh signalling. On stimulation of Hh, protein kinase A and CK1 sequentially phosphorylate the cytoplasmic domain of the Smoothened receptor, leading to the inhibition of Ci phosphorylation and thus to the activation of Hh signalling [28] [29] [30] .
METHODS
Plasmids. VSVG (YTDIEMNRLGK)-tagged LRP6, LRP6m5, LDLRDN-PPPSP and LDLRDN-PPPAP, Flag-tagged Axin, haemagglutinin (HA)-tagged GSK3b and GSK3bKM in pCS2þ have been described 5, 7 . VSVG-tagged LRP6m5 0 and Figure 4 | Membrane-associated GSK3 phosphorylates LRP6 and activates LRP6 and TCF/b-catenin signalling. a, Membrane-associated GSK3a/b and CK1a/1 is independent of Wnt3a stimulation. GSK3a/b (10%) and CK1a/1 (20%) were detected in the membrane fraction, which was marked by the transferrin receptor (TfR) and a lack of a-tubulin. Wnt3a stabilized cytosolic b-catenin. b, mGSK3b, like GSK3b, promoted LRP6 PPPSP phosphorylation. mGSK3b (VSVG-tagged) and GSK3b (HA-tagged) were detected with the two antibodies. c, d, TCF/b-catenin reporter assays. mGSK3b activated, whereas GSK3b inhibited, LRP6 signalling (c). mGSK3b
did not synergize with LRP6m5; the slight stimulation seen might be due to the endogenous LRP5/6 (d). WT, wild type. e, f, mGSK3b synergized with LRP6 to induce axis duplication (e) and Xnr3 expression (f) in Xenopus embryos. RNA doses injected are per embryo. The number above each bar in e indicates the number of embryos injected. f, Reverse transcriptasemediated polymerase chain reaction assay. EF-1a, loading control; 2RT, without reverse transcriptase; con, uninjected embryos. Luciferase activity is presented as fold induction compared with the control (mean^s.d.).
LRP6m10 were generated by sequential mutagenesis from VSVG-LRP6 in pCS2þ with the use of the QuickChange Kit (Stratagene). HA-GSK3b(R96A) was generated by site-directed mutagenesis of HA-GSK3b in pCS2þ. mGSK3 was generated by replacing the last 11 amino acid residues of VSVG-tagged LDLRDN 5 with the coding sequence of Gsk3b. Myc-tagged DN-CKIa and DN-CKId will be described elsewhere (details are available from the authors). GST-LRP6C and GST-LRP6N1 are in pGEX with the GST coding region fused in-frame to the entire (residues 1397-161'3) and a partial (residues 1397-1534) cytoplasmic domain of LRP6, respectively. Details of the plasmids are available from the authors on request. Antibodies. The polyclonal antibody Ab1490 has been described 5 . Polyclonal Ab1493 was generated similarly except that the synthetic phosphopeptide CLNPPPSPAT*ERSH (in which T* represents phosphothreonine) was used as the immunogen. Other antibodies were used in accordance with the manufacturers' instructions: anti-b-catenin, C2206 (Sigma); anti-phospho-b-catenin, S33/S37/T41 (Cell Signaling); anti-VSVG, V4888 (Sigma); anti-a-tubulin, sc8053 (Santa Cruz); anti-HA, Sc7392 (Santa Cruz); anti-Myc, A14 (Santa Cruz); anti-Flag, M2 (Sigma); anti-GSK3, 4G-1E (Upstate); anti-transferrin receptor, 13-6800 (Zymed); anti-CKI1, 610445 (BD Transduction Lab); and anti-CKIa, sc-6477 (Santa Cruz). Cell culture, Wnt induction, transfections and reporter assays. 293T cells were used unless MEFs were specifically mentioned. 293T cells or MEFs stably expressing VSVG-LRP6 or Flag-tagged Axin were established by means of puromycin selection after co-transfection of LRP6 or Axin with the pBABE puro plasmid. These lines have essentially the same Wnt response as parental cells (not shown). MEFs and 293T cells were maintained in DMEM medium supplemented with 10% FBS and 1% penicillin-streptomycin-glutamine. Transfections were conducted with Fugene6 (Roche). Luciferase assays were performed in 293T cells in duplicates as described previously 5 , with 0.3 mg of TCF-luciferase reporter plasmid plus 50 ng of Renilla luciferase plasmid (internal control) per well in the 12-well plate. Each experiment was repeated at least three times. Luciferase activity, presented as fold induction compared with the control, is shown as mean^s.d. For induction of LRP6 phosphorylation, cells were treated for 1 h with Wnt3a CM (collected from mouse L cells stably expressing Wnt3a, from ATCC) unless indicated otherwise. Cre-mediated deletion of Gsk3a alleles in Gsk3b 2/2 ;Gsk3a flox/flox MEFs. Gsk3a 2/2 ;Gsk3b 2/2 MEFs failed to survive after several passages. Gsk3b 2/2 ;Gsk3a flox/flox MEFs (Supplementary Information) were freshly infected with an adenoviral Cre expression system to delete both alleles of the Gsk3a gene and were maintained for a further 3 days for maximal turnover of the residual GSK3a protein before each experiment. After Cre expression, these MEFs exhibit normal response to epidermal growth factor and contain high levels of b-catenin protein as expected (not shown). Control MEFs infected with the Cre expression system exhibited normal Wnt3a induction of LRP6 phosphorylation (not shown). Manipulations of Xenopus laevis embryos. Synthetic RNAs were transcribed in vitro with MessageMachine (Ambion) and were injected into the animal region at the two-cell stage for Xnr3 induction in animal pole explants or ventrally at the four-cell stage for axis duplication. Procedures for embryo staging, injection and animal pole explants have been described 3 .
